New heart attack blood test could save NHS millions …

DO MAKE USE of LINKS,
>SEARCH<
&
>Side Bars<
&
The Top Bar >PAGES<

~~~~~~~~~~#########~~~~~~~~~~

.

New heart attack blood test could save NHS millions …

.
~~~~~~~~~~#########~~~~~~~~~~

Posted by:
Greg Lance – Watkins
Greg_L-W

eMail:
Greg_L-W@BTconnect.com

The BLOG:
https://InfoWebSiteUK.wordpress.com

The Main Web Site:
www.InfoWebSite.UK

~~~~~~~~~~#########~~~~~~~~~~

 .

Hi,

New heart attack blood test could save NHS millions

St Thomas’ hospital in London, which undertakes 7,800 heart attack tests a year, would be in line to save £800,000 alone.

More than two-thirds of people who go to A&E with chest pains have not had a heart attack
Image: More than two-thirds of people who go to A&E with chest pains have not had a heart attack

A blood test that speeds up the diagnosis of heart attacks could save the NHS millions of pounds every year, according to new research.

The new test is much more accurate than the one currently used and could free up doctors’ time and NHS beds.

 

More than two-thirds of people who go to A&E with chest pains have not suffered a heart attack.

But all of those patients undergo a blood test when they arrive and again three hours later to try and detect damage to the heart muscle.

The current test works by analysing biomarkers – including cardiac troponin. Those with undetectable levels of cardiac troponin are classified as low risk and are discharged from hospital.

But up to 85% of all patients fall into an intermediate risk group and require an overnight stay and further blood tests.

Scientists from King’s College London have developed a new test which looks at another biomarker – cardiac myosin-binding protein C (cMyC) – which is more sensitive to damage in the heart muscle.

Levels of cMyC in the blood increase rapidly after a heart attack – to a higher extent than troponin.

The new test – which could be rolled out across the NHS in the next five years – can detect a heart attack much more rapidly and could see those not suffering a heart attack sent home sooner.

The study, on more than 2,000 people in Switzerland, Italy and Spain, was funded by the British Heart Foundation (BHF) and published in the journal Circulation.

It found that the new test doubled the number of patients diagnosed as not having a heart attack.

Experts worked out that just one UK hospital – St Thomas’ in London which carries out 7,800 heart attack tests each year – could save £800,000 a year in reduced admissions and freed up beds.

Dr Tom Kaier, one of the lead researchers, said: “We often see patients in hospital who have to stay for further tests as a result of a mildly abnormal blood test – this is stressful and often unnecessary.

“Our research shows that the new test has the potential to reassure many thousands more patients with a single test, improving their experience and freeing up valuable hospital beds in A&E departments and wards across the country.”

To see the original of this article CLICK HERE

‘Instant’ blood test for heart attacks

  • 27 September 2017

A blood test that could rule out a heart attack in under 20 minutes should be used routinely, say UK researchers.

A team from King’s College London have tested it on patients and say the cMyC test could be rolled out on the NHS within five years.

They claim it would save the health service millions of pounds each year by freeing up beds and sending well patients home.

About two-thirds of patients with chest pain will not have had a heart attack.

A heart trace, called an ECG, can quickly show up major heart attacks, but it is not very good at excluding more common, smaller ones that can still be life-threatening.

Currently, patients with suspect chest pain and a clear ECG can have a different heart-attack blood test, called troponin, when they arrive at A&E. But it needs to be repeated three hours later to pick up signs of heart muscle damage.

Alison Fullingham, 49 and from Bolton, did not realise she was having a heart attack when she experienced pain in her upper chest, neck and jaw.

Despite a small change in her ECG, doctors initially suspected she was having a simple panic attack.

It was only hours later when her troponin tests came back that the correct diagnosis was reached.

Rapid diagnosis

Levels of cMyC (cardiac myosin-binding protein C) in the blood rise more rapidly and to a higher extent after a heart attack than troponin proteins, studies suggest.

That means doctors can use the new test to rule out a heart attack in a higher proportion of patients straightaway, according to the researchers who report their trial findings in the journal Circulation.

They carried out troponin and cMyC blood tests on nearly 2,000 people admitted to hospitals in Switzerland, Italy and Spain with acute chest pain.

The new test was better at giving patients the all-clear within the first three hours of presenting with chest pain.

Dr Tom Kaier, one of the lead researchers, funded by the British Heart Foundation (BHF) at St Thomas’ Hospital, London, said: “Our research shows that the new test has the potential to reassure many thousands more patients with a single test, improving their experience and freeing up valuable hospital beds in A&E departments and wards across the country.”

He says if the test were to be used routinely, it could provide doctors with reliable results within 15 to 30 minutes. It is only being used for research at the moment, however.

Dr Kaier’s hospital carries out around 7,800 troponin blood tests each year. By his calculations, switching to cMyC would save his hospital £800,000 through reduced admissions. Extrapolate that to other NHS hospitals and the savings could be millions of pounds, he says.

Prof Simon Ray, from the British Cardiovascular Society, said more research was needed before the new test could replace the troponin test.

“Unlike currently available blood tests which need to be repeated at least three hours after pain it looks as though a single test is enough to make a confident decision on whether a patient has or has not suffered a heart attack. Not only can it be done earlier after the onset of symptoms but it also seems to be better at discriminating between heart attacks and other causes of chest pains. This is very important.”

To view the Original Article CLICK HERE

.
Regards,
     Greg_L-W
Greg Lance-Watkins
.
 Please Be Sure To
& Link to my My Blogs
To Spread The Facts World Wide To Give Others HOPE
I Have Been Fighting Cancer since 1997 & I’M STILL HERE!
I Have Cancer, Cancer Does NOT Have Me
I just want to say sorry for copping out at times and leaving my wife Lee and friends to cope!
Any help and support YOU can give her will be hugely welcome.
I do make a lousy patient!

.

If YOU want to follow my fight against Cancer from when it started and I first presented with symptoms in 1998 see The TAB at the Header of this Blog. called >DIARY of Cancer ….ARCHIVEMEDICAL LINKSCANCER LINKSHOT LINKS< in the Sidebar.
.
YOU are welcome to call me, minded that I am NOT medically trained, if you believe I can help you in ANY way. .

Regards,
Greg_L-W.

~~~~~~~~~~#########~~~~~~~~~~
.
Posted by: Greg Lance-Watkins
tel: 44 (0)1594 – 528 337
Calls from ‘Number Withheld’ phones Are Blocked

All unanswered messages are recorded.
Leave your name & a UK land line number & I will return your call.

‘e’Mail Address: Greg_L-W@BTconnect.com

Skype: GregL-W

TWITTER: @Greg_LW

DO MAKE USE of LINKS,
>SEARCH<
&
>Side Bars<
&
The Top Bar >PAGES<
I try to make every effort to NOT infringe copyrights in any commercial way & make all corrections of fact brought to my attention by an identifiable individual
.

Please Be Sure To
.Follow Greg_LW on Twitter.

Re-TWEET my Twitterings
https://twitter.com/Greg_LW

& Publicise

My MainWebSite & Blogs

To Spread The Facts World Wide


eMail:
Greg_L-W@BTconnect.com

The BLOG:
https://InfoWebSiteUK.wordpress.com

The Main Web Site:
www.InfoWebSite.UK

~~~~~~~~~~#########~~~~~~~~~~

Enhanced by Zemanta
Advertisements

IN MEMORIAM – A Tribute To David Tang 02-Aug-1954 > 30-Aug-2017, from within the fashion industry …

DO MAKE USE of LINKS,
>SEARCH<
&
>Side Bars<
&
The Top Bar >PAGES<

~~~~~~~~~~#########~~~~~~~~~~

.

IN MEMORIAM – A Tribute To David Tang 02-Aug-1954 > 30-Aug-2017, from within the fashion industry …

.
~~~~~~~~~~#########~~~~~~~~~~

Posted by:
Greg Lance – Watkins
Greg_L-W

eMail:
Greg_L-W@BTconnect.com

The BLOG:
https://InfoWebSiteUK.wordpress.com

The Main Web Site:
www.InfoWebSite.UK

~~~~~~~~~~#########~~~~~~~~~~

 .

Hi,

having so recently posted David Tang’s praise of the NHS on 07-Aug-2017 it was sad to read of his demise.

If you missed my earlier article CLICK HERE

A Tribute To David Tang

Emma Weymouth pays tribute to her close friend and Shanghai Tang founder David Tang: a brilliant man who was loved so much and will be missed by so many


THERE are no words to do justice to David Tang, and as I write I can imagine him scoffing, correcting my grammar and blasting me with a one-liner to well and truly put me in my place. Always keeping us on our toes, one step ahead and ready at the drop of a hat to say something shocking at the top of his booming voice, outrageous enough to reduce a room full of his esteemed guests to a quivering mass of raucous laughter. Among countless other attributes, we loved him for his ruthless sense of humour – if you told him you’d lost 10 pounds, he would look you calmly in the eye and say, “What, sterling?” then chuckle with his familiar grin and happy snort. He was certainly the funniest, most intelligent and supremely generous friend any of us will ever have.

The inimitable David Tang

Getty Images

This week we lost one of the greats. A wit like no other, a philanthropist and businessman who could outdo us all, whether quoting Plato, playing a piano concerto with elegance and showmanship, or retelling one of the world’s naughtiest jokes in Chinese. On arriving at China Tang one Sunday evening for a late dinner, my husband Ceawlin and I happened upon David, who invited us to join his table, full of familiar faces. A few moments later, Tom Jones stood up and serenaded us all with his rendition of “Kiss”, to the delight of everyone.

David was a maker of magic, literally and figuratively. I remember an afternoon at his and his wife Lucy’s idyllic coastal country house in Sai Kung, Hong Kong, and no matter how hard David tried, one of his old classic card tricks kept failing to work. This enraged him beyond belief, but made the day even more entertaining.

Edward Tang, David’s son, and I met on our first day at UCL, and stuck together for our three-year History of Art course. We have remained firm friends ever since. Ed is godfather to our son John, and I have always adored him, but never have I been prouder of him or loved him more than I do now. This after all is not only a tribute to David, but also to his wonderful family, who have doted on him, held his hand and comforted him up to his last breath. Lucy has been his rock, and was the blood in his veins. Stoical to the last, she has faithfully supported David and calmly kept on top of everything, whilst navigating an emotional rollercoaster too terrible to imagine. The support, too, of David’s beloved and talented daughter Victoria has been unparalleled, with her husband Chris and beautiful baby Rocco alongside, providing the tenderness and companionship any of us would wish for during our last moments in this life.

LikeComment
376 likes

The light that shone from David inspired us all, and can never be extinguished. I can think of no one else who has brought such immeasurable joy to so many of our lives, with the driving force of a Superman and the energy of 50. Even when his health began to fade, his mind remained robust to the very last. The China Exchange, an ideas space that David founded as a “dynamic centre of excellence in Chinatown”, will continue to host varied and thought-provoking events, just as he intended. At his farewell party, the many embraces of his cherished friends will be the lasting symbol of the adoration and admiration we feel for him – an irreplaceable soul. We will celebrate him, treasure our precious memories of him and keep him with us in our hearts forever.

To see the original of this article CLICK HERE
.
Regards,
     Greg_L-W
Greg Lance-Watkins
.
 Please Be Sure To
& Link to my My Blogs
To Spread The Facts World Wide To Give Others HOPE
I Have Been Fighting Cancer since 1997 & I’M STILL HERE!
I Have Cancer, Cancer Does NOT Have Me
I just want to say sorry for copping out at times and leaving my wife Lee and friends to cope!
Any help and support YOU can give her will be hugely welcome.
I do make a lousy patient!

.

If YOU want to follow my fight against Cancer from when it started and I first presented with symptoms in 1998 see The TAB at the Header of this Blog. called >DIARY of Cancer ….ARCHIVEMEDICAL LINKSCANCER LINKSHOT LINKS< in the Sidebar.
.
YOU are welcome to call me, minded that I am NOT medically trained, if you believe I can help you in ANY way. .

Regards,
Greg_L-W.

~~~~~~~~~~#########~~~~~~~~~~
.
Posted by: Greg Lance-Watkins
tel: 44 (0)1594 – 528 337
Calls from ‘Number Withheld’ phones Are Blocked

All unanswered messages are recorded.
Leave your name & a UK land line number & I will return your call.

‘e’Mail Address: Greg_L-W@BTconnect.com

Skype: GregL-W

TWITTER: @Greg_LW

DO MAKE USE of LINKS,
>SEARCH<
&
>Side Bars<
&
The Top Bar >PAGES<
I try to make every effort to NOT infringe copyrights in any commercial way & make all corrections of fact brought to my attention by an identifiable individual
.

Please Be Sure To
.Follow Greg_LW on Twitter.

Re-TWEET my Twitterings
https://twitter.com/Greg_LW

& Publicise

My MainWebSite & Blogs

To Spread The Facts World Wide


eMail:
Greg_L-W@BTconnect.com

The BLOG:
https://InfoWebSiteUK.wordpress.com

The Main Web Site:
www.InfoWebSite.UK

~~~~~~~~~~#########~~~~~~~~~~

Enhanced by Zemanta

#Anacetrapib the New drug reduces heart attacks, but is that enough? …

DO MAKE USE of LINKS,
>SEARCH<
&
>Side Bars<
&
The Top Bar >PAGES<

~~~~~~~~~~#########~~~~~~~~~~

.

#Anacetrapib the New drug reduces heart attacks, but is that enough? …

.
~~~~~~~~~~#########~~~~~~~~~~

Posted by:
Greg Lance – Watkins
Greg_L-W

eMail:
Greg_L-W@BTconnect.com

The BLOG:
https://InfoWebSiteUK.wordpress.com

The Main Web Site:
www.InfoWebSite.UK

~~~~~~~~~~#########~~~~~~~~~~

 .

Hi,

New drug reduces heart attacks, but is that enough?

A large, long-term study of the drug showed that it prevents heart attacks and reduces the need for heart procedures, while three similar drugs developed by rivals failed. But the drug, anacetrapib, only reduced those complications by 9 percent.

Now Merck, which has spent 13 years and likely hundreds of millions of dollars testing the drug, has to decide whether to spend even more to seek approval from regulators and convince people to buy it in a market full of cholesterol drugs.

FILE - This Thursday, Dec.18, 2014, file photograph, shows the Merck logo on a stained glass panel at a Merck company building in Kenilworth, N.J. A new type of cholesterol drug meant to prevent heart attacks and other complications clearly did so, in an unusually large study whose results were announced Tuesday, Aug. 29, 2017, at a conference of heart specialists. But the daily pill only reduced those complications by 9 percent, leaving drugmaker Merck with a tough call on whether to seek regulatory approval after spending 13 years and likely hundreds of millions of dollars on testing. (AP Photo/Mel Evans, File)

FILE – This Thursday, Dec.18, 2014, file photograph, shows the Merck logo on a stained glass panel at a Merck company building in Kenilworth, N.J.

A new type of cholesterol drug meant to prevent heart attacks and other complications clearly did so, in an unusually large study whose results were announced Tuesday, Aug. 29, 2017, at a conference of heart specialists. But the daily pill only reduced those complications by 9 percent, leaving drugmaker Merck with a tough call on whether to seek regulatory approval after spending 13 years and likely hundreds of millions of dollars on testing. (AP Photo/Mel Evans, File)

The results of the 30,450-patient study were announced Tuesday at a conference of heart specialists in Barcelona, Spain and published in the New England Journal of Medicine. The study found that anacetrapib is safe and somewhat effective.

That kind of result is normally enough to seek approval to market a new medicine, especially for heart disease, which is the top killer in many developed countries. Yet even after seeing the results weeks ago, Merck says its executives are still consulting with medical experts and regulators on whether to go through the costly process of applying for approval.

Analyst Steve Brozak, president of WBB Securities, predicts Merck will do so, given anacetrapib’s safety, the huge pool of potential patients and all the resources Merck has poured into the drug.

“This will get used,” Brozak said.

Merck would likely price the bill somewhere between the two extremes that now define the market for cholesterol drugs.

Generic versions of brand-name statin cholesterol pills including Lipitor, Crestor and Merck’s own Zocor now cost $10 to $20 a month. Repatha and Praluent, two new injected medicines in a different drug category that have been shown to dramatically reduce cholesterol, cost $14,000 a year.

Georgetown University cardiologist Dr. Allen J. Taylor said he thinks the drug would be approved by the Food and Drug Administration despite its “relatively weak benefit.”

“If you were discussing this with patients,” Taylor said, “you would have to tell them that when you start this, you’ll have to take it for four years to have a 1 percent chance of preventing an event,” meaning a heart attack or a procedure such as bypass surgery or implanting a stent to keep an artery open.

Taylor said it’s still unclear how anacetrapib controls cholesterol, which would make it hard for doctors to determine which patients would benefit much from it. But he and Brozak praised the company for doing such an exhaustive, expensive study in an era when many studies are quick and relatively small, sometimes producing unclear results.

In the study, patients getting anacetrapib plus a statin for four years had, on average, lower levels of bad cholesterol and other fats, and higher levels of good cholesterol, compared to a group getting a statin and a dummy pill. But Merck’s drug didn’t prevent any deaths from heart attacks or other cardiac problems.

Anacetrapib’s only worrisome side effect was a long-term accumulation of the drug in patients’ fatty tissue. It’s unknown if that will cause problems, so Merck plans to study that by following some participants for two years after they stop taking the drug.

 

To see the original of this article CLICK HERE
.
Regards,
     Greg_L-W
Greg Lance-Watkins
.
 Please Be Sure To
& Link to my My Blogs
To Spread The Facts World Wide To Give Others HOPE
I Have Been Fighting Cancer since 1997 & I’M STILL HERE!
I Have Cancer, Cancer Does NOT Have Me
I just want to say sorry for copping out at times and leaving my wife Lee and friends to cope!
Any help and support YOU can give her will be hugely welcome.
I do make a lousy patient!

.

If YOU want to follow my fight against Cancer from when it started and I first presented with symptoms in 1998 see The TAB at the Header of this Blog. called >DIARY of Cancer ….ARCHIVEMEDICAL LINKSCANCER LINKSHOT LINKS< in the Sidebar.
.
YOU are welcome to call me, minded that I am NOT medically trained, if you believe I can help you in ANY way. .

Regards,
Greg_L-W.

~~~~~~~~~~#########~~~~~~~~~~
.
Posted by: Greg Lance-Watkins
tel: 44 (0)1594 – 528 337
Calls from ‘Number Withheld’ phones Are Blocked

All unanswered messages are recorded.
Leave your name & a UK land line number & I will return your call.

‘e’Mail Address: Greg_L-W@BTconnect.com

Skype: GregL-W

TWITTER: @Greg_LW

DO MAKE USE of LINKS,
>SEARCH<
&
>Side Bars<
&
The Top Bar >PAGES<
I try to make every effort to NOT infringe copyrights in any commercial way & make all corrections of fact brought to my attention by an identifiable individual
.

Please Be Sure To
.Follow Greg_LW on Twitter.

Re-TWEET my Twitterings
https://twitter.com/Greg_LW

& Publicise

My MainWebSite & Blogs

To Spread The Facts World Wide


eMail:
Greg_L-W@BTconnect.com

The BLOG:
https://InfoWebSiteUK.wordpress.com

The Main Web Site:
www.InfoWebSite.UK

~~~~~~~~~~#########~~~~~~~~~~

Enhanced by Zemanta

#Canakinumab Is Clearly The New Wonder Drug For Patients With #Heart_Attacks …

DO MAKE USE of LINKS,
>SEARCH<
&
>Side Bars<
&
The Top Bar >PAGES<

~~~~~~~~~~#########~~~~~~~~~~

.

#Canakinumab Is Clearly The New Wonder Drug For Patients With #Heart_Attacks …

.
~~~~~~~~~~#########~~~~~~~~~~

Posted by:
Greg Lance – Watkins
Greg_L-W

eMail:
Greg_L-W@BTconnect.com

The BLOG:
https://InfoWebSiteUK.wordpress.com

The Main Web Site:
www.InfoWebSite.UK

~~~~~~~~~~#########~~~~~~~~~~

 .

Hi,

Best heart drug since statins: New injection could save thousands of lives by preventing heart attacks and also slash cancer risk

  • Landmark four-year trial found Canakinumab  cut heart attack risk by 24 per cent
  • The study also suggested it could halve the risk of dying from lung cancer
  • Scientists have hailed the find and said treatment could save thousands of lives 
A breakthrough drug could prevent thousands of heart attacks (stock picture)

A breakthrough drug could prevent thousands of heart attacks (stock picture)

Thousands of lives could be saved thanks to a new heart drug hailed as the biggest breakthrough since statins.

In a landmark four-year trial, scientists found that the drug – given by injection every three months – cut the risk of heart attacks by a quarter.

The 10,000-patient study, involving 1,000 doctors in 39 countries, also suggested it could halve the risk of dying from lung cancer and prevent arthritis and gout.

Scientists last night said the treatment marked ‘a new era of therapeutics’ that could save thousands of lives.

The drug, Canakinumab, works by reducing inflammation – a major new approach in heart medicine.

For the past 30 years cholesterol-busting statins have been given to nearly all people deemed to be at risk of cardiovascular disease in a bid to save them from heart attacks and strokes. Yet half of the 200,000 people who have a heart attack in Britain each year do not have high cholesterol, meaning there is a desperate need for a different approach to treatment.

Experts have long thought that inflammation – the body’s natural responses to infection or injury – might also play a major role in causing heart attacks and strokes, possibly because it causes the condition to flare in the arteries, increasing the risk of a blockage.

In a landmark four-year trial, scientists found that the drug - given by injection every three months – cut the risk of heart attacks by 24 per cent (stock picture)

 

In a landmark four-year trial, scientists found that the drug – given by injection every three months – cut the risk of heart attacks by 24 per cent (stock picture)

The new trial, however, is the first definitive proof that cutting inflammation slashes heart risk.

Study leader Professor Paul Ridker of Harvard Medical School said the new drug opened up a ‘third front’ in the war on heart disease, following the previous focus on cholesterol and lifestyle.

Presenting his findings at the European Society of Cardiology congress in Barcelona yesterday, Prof Ridker said: ‘These findings represent the end game of more than two decades of research, stemming from a critical observation – half of heart attacks occur in people who do not have high cholesterol.

‘For the first time, we’ve been able to definitively show that lowering inflammation independent of cholesterol reduces cardiovascular risk.’

Prof Ridker, whose results are published in the New England Journal of Medicine, added: ‘This has far-reaching implications.

Ease back on salt 

Eating too much salt more than doubles the risk of heart failure, scientists have found.

Experts have long known that salt increases high-blood pressure – but the new research suggests it also does direct damage to the heart.

Researchers at the National Institute for Health and Welfare in Helsinki tracked 4,630 healthy adults for 12 years.

They found 20 per cent of people were eating more than 13.7g daily. The UK guideline is 6g.

These people were twice as likely to suffer heart failure than those who ate less than 6.8g. Lead researcher Professor Pekka Jousilahti said: ‘The heart does not like salt. High salt intake markedly increases the risk of heart failure.’

 

‘It tells us that by leveraging an entirely new way to treat patients – targeting inflammation – we may be able to significantly improve outcomes for certain very high-risk populations.’

Canakinumab is an antibody that attacks an immune-system protein called interleukin-1, which in high levels results in increased inflammation throughout the body.

The trial involved high-risk patients who had already suffered a heart attack – a group in desperate need of help because a quarter of patients suffer a second attack within five years, even with statins.

All patients in the trial took statins as well, but the research team found the addition of Canakinumab cut the risk of repeat heart attacks by 24 per cent, over and above the impact of the cholesterol drug.

People who took the drug were also 36 per cent less likely to be hospitalised with unstable angina, and 32 per cent less likely to require expensive interventional procedures such as bypass surgery.

Researchers reported a sharp rise in infections – a side effect linked to the fact inflammation protects against infection – which killed one in every 1,000 patients.

But they also found patients had a 51 per cent reduced risk of lung cancer deaths – a finding they said was ‘very exciting’ and needed further trials. Gout and arthritis, which are linked to inflammation, also fell.

Drugs giant Novartis, which makes Canakinumab, said it would immediately apply for a medical licence to use the drug for heart disease.

All patients in the trial took statins as well, but the research team found the addition of Canakinumab cut the risk of repeat heart attacks by 24 per centAll patients in the trial took statins as well, but the research team found the addition of Canakinumab cut the risk of repeat heart attacks by 24 per cent

Canakinumab is used for inflammatory problems, including rare forms of arthritis, at the cost of £9,928 per jab. It is expensive because the conditions are rare, so sales are low. Experts said the price – £40,000 a year for heart patients – would have to come down if it were to be made available on the NHS.

Professor Jeremy Pearson, of the British Heart Foundation, said: ‘These exciting and long-awaited trial results finally confirm that ongoing inflammation contributes to risk of heart disease, and could help save lives.’

American cardiologist Steven Nissen said: ‘This is as big as anything we’ve seen in a while. It’s a gateway to a very wide variety of therapies that are going to be developed.’

To see the original of this article CLICK HERE
.
Regards,
     Greg_L-W
Greg Lance-Watkins
.
 Please Be Sure To
& Link to my My Blogs
To Spread The Facts World Wide To Give Others HOPE
I Have Been Fighting Cancer since 1997 & I’M STILL HERE!
I Have Cancer, Cancer Does NOT Have Me
I just want to say sorry for copping out at times and leaving my wife Lee and friends to cope!
Any help and support YOU can give her will be hugely welcome.
I do make a lousy patient!

.

If YOU want to follow my fight against Cancer from when it started and I first presented with symptoms in 1998 see The TAB at the Header of this Blog. called >DIARY of Cancer ….ARCHIVEMEDICAL LINKSCANCER LINKSHOT LINKS< in the Sidebar.
.
YOU are welcome to call me, minded that I am NOT medically trained, if you believe I can help you in ANY way. .

Regards,
Greg_L-W.

~~~~~~~~~~#########~~~~~~~~~~
.
Posted by: Greg Lance-Watkins
tel: 44 (0)1594 – 528 337
Calls from ‘Number Withheld’ phones Are Blocked

All unanswered messages are recorded.
Leave your name & a UK land line number & I will return your call.

‘e’Mail Address: Greg_L-W@BTconnect.com

Skype: GregL-W

TWITTER: @Greg_LW

DO MAKE USE of LINKS,
>SEARCH<
&
>Side Bars<
&
The Top Bar >PAGES<
I try to make every effort to NOT infringe copyrights in any commercial way & make all corrections of fact brought to my attention by an identifiable individual
.

Please Be Sure To
.Follow Greg_LW on Twitter.

Re-TWEET my Twitterings
https://twitter.com/Greg_LW

& Publicise

My MainWebSite & Blogs

To Spread The Facts World Wide


eMail:
Greg_L-W@BTconnect.com

The BLOG:
https://InfoWebSiteUK.wordpress.com

The Main Web Site:
www.InfoWebSite.UK

~~~~~~~~~~#########~~~~~~~~~~

Enhanced by Zemanta

Heart attack and cancer deaths could be cut by a new drug …

DO MAKE USE of LINKS,
>SEARCH<
&
>Side Bars<
&
The Top Bar >PAGES<

~~~~~~~~~~#########~~~~~~~~~~

.

Heart attack and cancer deaths could be cut by a new drug …

.
~~~~~~~~~~#########~~~~~~~~~~

Posted by:
Greg Lance – Watkins
Greg_L-W

eMail:
Greg_L-W@BTconnect.com

The BLOG:
https://InfoWebSiteUK.wordpress.com

The Main Web Site:
www.InfoWebSite.UK

~~~~~~~~~~#########~~~~~~~~~~

 .

Hi,

Heart attack and cancer deaths could be cut by new drug

A study on an anti-inflammatory shows a 15% reduction in heart attack risk and the number of cancer deaths cut by half.

Stock photo ID:627196908
Upload date:January 04, 2017
Image: Results of the trial have been described as ‘very exciting’

A new drug that could help reduce the risk of heart attacks and cut cancer deaths has been hailed as an “exciting” breakthrough.

Canakinumab, an anti-inflammatory, was used in a trial involving more than 10,000 patients, all of whom have had a heart attack but had not been diagnosed with cancer.

 

They were treated with the drug, which is given by injection, once every three months and monitored for up to four years.

The study showed a 15% reduction in the risk of heart attacks and strokes and the number of cancer deaths cut by half.

One of the researchers, Dr Paul Ridker of Brigham and Women’s Hospital in Boston, said the findings have “far-reaching implications”.

He said: “For the first time, we’ve been able to definitively show that lowering inflammation independent of cholesterol reduces cardiovascular risk.

“It tells us that by leveraging an entirely new way to treat patients – targeting inflammation – we may be able to significantly improve outcomes for certain very high-risk populations.”

The benefits seen in the patients were “above and beyond” those seen in patients who just took statins, the hospital said.

Dr Ridker said: “In my lifetime, I’ve gotten to see three broad eras of preventative cardiology.

“In the first, we recognised the importance of diet, exercise and smoking cessation. In the second, we saw the tremendous value of lipid-lowering drugs such as statins. Now, we’re cracking the door open on the third era.

“This is very exciting.”

Regarding the cancer findings, Dr Ridker said more research was needed but there was the “possibility of slowing the progression of certain cancers”.

Gary Gibbons, director of the National Heart, Lung, and Blood Institute, said: “Although this trial provides compelling evidence that targeting inflammation has efficacy in preventing recurrent cardiovascular events, we look forward to findings from additional trials, such as the NHLBI-funded Cardiovascular Inflammation Reduction Trial, to further refine the best therapeutic strategies for preventing cardiovascular disease.”

To see the original of this article CLICK HERE
.
Regards,
     Greg_L-W
Greg Lance-Watkins
.
 Please Be Sure To
& Link to my My Blogs
To Spread The Facts World Wide To Give Others HOPE
I Have Been Fighting Cancer since 1997 & I’M STILL HERE!
I Have Cancer, Cancer Does NOT Have Me
I just want to say sorry for copping out at times and leaving my wife Lee and friends to cope!
Any help and support YOU can give her will be hugely welcome.
I do make a lousy patient!

.

If YOU want to follow my fight against Cancer from when it started and I first presented with symptoms in 1998 see The TAB at the Header of this Blog. called >DIARY of Cancer ….ARCHIVEMEDICAL LINKSCANCER LINKSHOT LINKS< in the Sidebar.
.
YOU are welcome to call me, minded that I am NOT medically trained, if you believe I can help you in ANY way. .

Regards,
Greg_L-W.

~~~~~~~~~~#########~~~~~~~~~~
.
Posted by: Greg Lance-Watkins
tel: 44 (0)1594 – 528 337
Calls from ‘Number Withheld’ phones Are Blocked

All unanswered messages are recorded.
Leave your name & a UK land line number & I will return your call.

‘e’Mail Address: Greg_L-W@BTconnect.com

Skype: GregL-W

TWITTER: @Greg_LW

DO MAKE USE of LINKS,
>SEARCH<
&
>Side Bars<
&
The Top Bar >PAGES<
I try to make every effort to NOT infringe copyrights in any commercial way & make all corrections of fact brought to my attention by an identifiable individual
.

Please Be Sure To
.Follow Greg_LW on Twitter.

Re-TWEET my Twitterings
https://twitter.com/Greg_LW

& Publicise

My MainWebSite & Blogs

To Spread The Facts World Wide


eMail:
Greg_L-W@BTconnect.com

The BLOG:
https://InfoWebSiteUK.wordpress.com

The Main Web Site:
www.InfoWebSite.UK

~~~~~~~~~~#########~~~~~~~~~~

Enhanced by Zemanta

#Canakinumab #Novartis study shows drug may halve cancer deaths and cut heart attack risks …

DO MAKE USE of LINKS,
>SEARCH<
&
>Side Bars<
&
The Top Bar >PAGES<

~~~~~~~~~~#########~~~~~~~~~~

.

#Canakinumab #Novartis study shows drug may halve cancer deaths and cut heart attack risks …

.
~~~~~~~~~~#########~~~~~~~~~~

Posted by:
Greg Lance – Watkins
Greg_L-W

eMail:
Greg_L-W@BTconnect.com

The BLOG:
https://InfoWebSiteUK.wordpress.com

The Main Web Site:
www.InfoWebSite.UK

~~~~~~~~~~#########~~~~~~~~~~

 .

Hi,

`Milestone´ study shows drug may halve cancer deaths and cut heart attack risks

An “exciting” new study has revealed a drug that could help reduce the risk of heart attacks and cut cancer deaths.

More than 10,000 patients took part in a trial using the anti-inflammatory Canakinumab, the results of which were presented at the European Society of Cardiology meeting in Barcelona, Spain.

The patients, all of whom had previously had a heart attack but had not been diagnosed with cancer, were treated with the drug once every three months, and monitored for up to four years.

The Canakinumab Anti-inflammatory Thrombosis Outcomes study, or CANTOS, showed a 15% reduction in the risk of heart attacks and strokes, and cancer deaths cut in half, the hospital where one of the lead authors is based said.

John Stilwell
 

John Stilwell

Dr Paul Ridker of Brigham and Women’s Hospital in Boston, said the study “represents a milestone in a long journey”, adding that the findings “usher in a new era of therapeutics”.

He said: “For the first time, we’ve been able to definitively show that lowering inflammation independent of cholesterol reduces cardiovascular risk.

“This has far-reaching implications. It tells us that by leveraging an entirely new way to treat patients – targeting inflammation – we may be able to significantly improve outcomes for certain very high-risk populations.”

The hospital said the reductions in risk were “above and beyond” those seen in patients who only took statins.

Statins
 

Statins

Dr Ridker said the study showed another way to prevent repeated heart attacks, through the use of anti-inflammatories.

He said: “In my lifetime, I’ve gotten to see three broad eras of preventative cardiology.

“In the first, we recognised the importance of diet, exercise and smoking cessation. In the second, we saw the tremendous value of lipid-lowering drugs such as statins. Now, we’re cracking the door open on the third era. This is very exciting.”

Gary Gibbons, director of the National Heart, Lung, and Blood Institute, said the results provided a platform on which to carry out further trials and research.

Stopping smoking, attending to diet and cutting down on alcohol are still the best primary steps to take (Jonathan Brady/PA)
 

Stopping smoking, attending to diet and cutting down on alcohol are still the best primary steps to take (Jonathan Brady/PA)

He said: “Although this trial provides compelling evidence that targeting inflammation has efficacy in preventing recurrent cardiovascular events, we look forward to findings from additional trials, such as the NHLBI-funded Cardiovascular Inflammation Reduction Trial, to further refine the best therapeutic strategies for preventing cardiovascular disease.”

In looking at the effects of the drug on cancer, Dr Ridker said the findings indicate “the possibility of slowing the progression of certain cancers” but said further research is required.

The study was funded by Novartis Pharmaceuticals.

To see the original of this article CLICK HERE
.
Regards,
     Greg_L-W
Greg Lance-Watkins
.
 Please Be Sure To
& Link to my My Blogs
To Spread The Facts World Wide To Give Others HOPE
I Have Been Fighting Cancer since 1997 & I’M STILL HERE!
I Have Cancer, Cancer Does NOT Have Me
I just want to say sorry for copping out at times and leaving my wife Lee and friends to cope!
Any help and support YOU can give her will be hugely welcome.
I do make a lousy patient!

.

If YOU want to follow my fight against Cancer from when it started and I first presented with symptoms in 1998 see The TAB at the Header of this Blog. called >DIARY of Cancer ….ARCHIVEMEDICAL LINKSCANCER LINKSHOT LINKS< in the Sidebar.
.
YOU are welcome to call me, minded that I am NOT medically trained, if you believe I can help you in ANY way. .

Regards,
Greg_L-W.

~~~~~~~~~~#########~~~~~~~~~~
.
Posted by: Greg Lance-Watkins
tel: 44 (0)1594 – 528 337
Calls from ‘Number Withheld’ phones Are Blocked

All unanswered messages are recorded.
Leave your name & a UK land line number & I will return your call.

‘e’Mail Address: Greg_L-W@BTconnect.com

Skype: GregL-W

TWITTER: @Greg_LW

DO MAKE USE of LINKS,
>SEARCH<
&
>Side Bars<
&
The Top Bar >PAGES<
I try to make every effort to NOT infringe copyrights in any commercial way & make all corrections of fact brought to my attention by an identifiable individual
.

Please Be Sure To
.Follow Greg_LW on Twitter.

Re-TWEET my Twitterings
https://twitter.com/Greg_LW

& Publicise

My MainWebSite & Blogs

To Spread The Facts World Wide


eMail:
Greg_L-W@BTconnect.com

The BLOG:
https://InfoWebSiteUK.wordpress.com

The Main Web Site:
www.InfoWebSite.UK

~~~~~~~~~~#########~~~~~~~~~~

Enhanced by Zemanta

David Tang: In Praise Of The NHS …

DO MAKE USE of LINKS,
>SEARCH<
&
>Side Bars<
&
The Top Bar >PAGES<

~~~~~~~~~~#########~~~~~~~~~~

.

David Tang: In Praise Of The NHS …

.
~~~~~~~~~~#########~~~~~~~~~~

Posted by:
Greg Lance – Watkins
Greg_L-W

eMail:
Greg_L-W@BTconnect.com

The BLOG:
https://InfoWebSiteUK.wordpress.com

The Main Web Site:
www.InfoWebSite.UK

~~~~~~~~~~#########~~~~~~~~~~

 .

Hi,

I noted this article whilst on my daily constitutional which comprises a scan of some 20-30 newspapers a day, for articles that inform me in areas I am interested in.

Although this health article is for neither cancer nor heart attack, it caught my eye as it was written by David Tang whose ability as a wordsmith has always interested me as has his turn of phrase and humour has always apealed.

David Tang’s eloquent praise for the NHS so clearly displayed how I feel about our Health Service, which contrary to the pointscoring efforts of the dullards who so often rise in politics and the vituperative though poorly researched efforts of the dumbed down MSM, as they hunt down cheap shots whilst searching the internet for stories, as they are no longer funded to do proper research nor in most cases trained for it.

Just like the MSM TV the press is dumbed down valuing gossip and tittletattle of the nebishes that pass themselves off as ‘slebs’, with a very small ‘s’.

I looked up David Tang some years ago & found he was 8 years my junior & thus would have been a mere 2 years old when I first came across his name in 1956. David Tang’s father was therenowned CK Tang who emigrated to Singapore in 1923 and founded CK Tang’s opening his first shop in 1932.

In 1956 I had first come across his store and used to walk into town to visit CK Tang’s, sometimes alone & sometimes with Adam Fong my Chinese friend. I was fascinated by the opportunity to lift the edge of China’s skirt and gaze at the mysteries – intricately carved consentric balls of ivory and entire pairs of tusks intricaly carved from end to end, and far taller than I.

Adam would answer my questions as for his age he had a tremendous knowledge of the gods and mythology of China and that which he did not know he would proudly tell me about once he had established the facts from his father who was the manager of the unpreposessingly named ‘Chicken Inn’ a superb restauraunt by my home in ‘Kampong’ in the building which had been the Japanese Kempetei HQ – right on the water front suspended over a small beach where neither the Malays, Tamils nor Chinese would goas they believed it was haunted by the souls – below the glass floor of their dinning room so that they could watch them being drowned and devoured by sharks as the tide came in! of the many prisoners the Japanese tied to stakes.

CK Tang’s was still there pulling me like a magnet in 1957 when I returned during Merdeka & the elections that brought Lee Kuan Yew to power with his political logo of a red chicken and his efforts to control TB, which was rife, by spot fines for spitting in the streets!

I eventually gave away my 5 volumes of books on Chinese gods & mythology each with camphor wood covers and concertina folded paintings on silk and the story of each scene in both Chinese and English.

I’d like David Tang to one day know the pleasure his father’s shop gave a small boy with limited pocket money on holiday in Singapore!

That David Tang had his life saved by the superb care of the NHS – Just as they have saved my life with various cancers and a consequential heart attack.

In praise of the NHS

‘The moment I was wheeled in, I knew this was nothing like my preconception of an A&E department’
Image of David Tang
NURSE 01
August 7, 2017 by: David Tang
On a beautiful Sunday morning I was looking out on a perfect olive tree in front of a turquoise crescent of water at St-Jean-Cap-Ferrat, with a couple of overnight local fishing boats bobbing gently against a perfect blue sky without a single cumulus.
Yet I was in pain.
Little did I know that, in the dark depths of the night before, I had an ulcer that had begun a sinister haemorrhage.
The beautiful sun rising outside was in total ignorance of my uglifying seepage inside.
My wife acted decisively for me. She called a friend who lent us his jet and, within four hours, we landed at RAF Northolt. I stood up to disembark but, not realising how weak I was, collapsed in the narrow gangway of the Global Express plane. I could not move and it took four strong men to slither me out of the plane on a sliding sheet into an ambulance.
And here the miracle, like a magic carpet, began.
They took me to Hillingdon hospital. Had I managed those five steps out of the plane myself, I would have made it to the London clinic where a private room was waiting for me.
This was now an extreme emergency and the NHS hospital was the only option.
Yet the moment I was wheeled into that hospital, I knew this was nothing like my preconception of an NHS A&E department, about which we hear so much criticism. Immediately, two doctors hovered over me with three nurses close by. I was swung into one of those blue-curtained spaces and asked a series of precise and pertinent questions.
Within minutes, they had diagnosed internal bleeding, and I was whisked upstairs to intensive care where I was given a blood transfusion.
No hesitation, no dithering: three bags full, like three blah blah black sheep, straight into my system.
More doctors came and asked more relevant questions.
Within another hour, I was taken for a CT scan, and another half-hour an endoscopy with an anaesthetist whereupon they identified a bleeding ulcer which they treated with immediate effect.
The long and the short of it was five doctors and 10 nurses saved my life at Hillingdon that Sunday afternoon.
ICU BED 01
I was moved into a general intensive care unit that evening and, for the first time in my life, experienced sleeping in an open ward in a long room with five beds on one side facing a long counter of doctors and nurses.
In the middle of the night, in my half slumber and weak waking moments, I realised that sleeping in a space like an open office was rather nicer than being cooped up in a private room.
It had never occurred to me that sharing with other patients and seeing the dependable shadows of the moving and half-whispering nurses could engender such a soothing and warming feeling.
I also felt a bond with my fellow patients.
I will howl and hunt down anyone who dares to question the NHS I woke and experienced another extraordinary day of meticulous care.
Each and every staff nurse, in their wonderful blue uniforms, could not have been more kind and helpful, including wiping me down with wit and humour, both of which, I can assure my readers, demanded a very high standard!
There was one exceptional doctor from Hungary who became one of my greatest friends without my knowing it. His application of knowledge and experience to my case was one of those rare occurrences when you know a piece of fortune has been stitched into the hem of your life.
So, ladies and gentlemen, let me tell you now the fountain of all serendipities:
if you were in the magical labyrinth of the Hillingdon NHS, you would, like I, never ever have a single doubt about the NHS as an institution of the greatest cultivation.
I will howl and hunt down anyone who dares to question the NHS.
Tonight, as I sleep at the Marsden, under another impermeable umbrella of the NHS, I pay my private tribute to the NHS, particularly to all my new best friends at the Hillingdon, and I also pay a public tribute to what they represent.
My mother always told me that the UK provided the best education in the world, to which I now add the best hospital care in the world.
The fact that it was free at the point of service defies even Einsteinian space-time.
So I am glad I have paid my taxes in this country — before with reluctance, but now with alacrity.
I hereby demote Asclepius and genuflect to Nye Bevan, founder of the NHS.
To see the original of this article CLICK HERE
.
Regards,
     Greg_L-W
Greg Lance-Watkins
.
 Please Be Sure To
& Link to my My Blogs
To Spread The Facts World Wide To Give Others HOPE
I Have Been Fighting Cancer since 1997 & I’M STILL HERE!
I Have Cancer, Cancer Does NOT Have Me
I just want to say sorry for copping out at times and leaving my wife Lee and friends to cope!
Any help and support YOU can give her will be hugely welcome.
I do make a lousy patient!

.

If YOU want to follow my fight against Cancer from when it started and I first presented with symptoms in 1998 see The TAB at the Header of this Blog. called >DIARY of Cancer ….ARCHIVEMEDICAL LINKSCANCER LINKSHOT LINKS< in the Sidebar.
.
YOU are welcome to call me, minded that I am NOT medically trained, if you believe I can help you in ANY way. .

Regards,
Greg_L-W.

~~~~~~~~~~#########~~~~~~~~~~
.
Posted by: Greg Lance-Watkins
tel: 44 (0)1594 – 528 337
Calls from ‘Number Withheld’ phones Are Blocked

All unanswered messages are recorded.
Leave your name & a UK land line number & I will return your call.

‘e’Mail Address: Greg_L-W@BTconnect.com

Skype: GregL-W

TWITTER: @Greg_LW

DO MAKE USE of LINKS,
>SEARCH<
&
>Side Bars<
&
The Top Bar >PAGES<
I try to make every effort to NOT infringe copyrights in any commercial way & make all corrections of fact brought to my attention by an identifiable individual
.

Please Be Sure To
.Follow Greg_LW on Twitter.

Re-TWEET my Twitterings
https://twitter.com/Greg_LW

& Publicise

My MainWebSite & Blogs

To Spread The Facts World Wide


eMail:
Greg_L-W@BTconnect.com

The BLOG:
https://InfoWebSiteUK.wordpress.com

The Main Web Site:
www.InfoWebSite.UK

~~~~~~~~~~#########~~~~~~~~~~

Enhanced by Zemanta